Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Ther Apher Dial ; 26 Suppl 1: 89-96, 2022 Dec.
Article in English | MEDLINE | ID: mdl-36468316

ABSTRACT

INTRODUCTION: Familial hypercholesterolemia (FH) is an autosomal codominant lipid metabolism disorder. It results in lifelong elevation of plasmatic low-density lipoprotein cholesterol (LDL-C) levels, followed by premature atherosclerosis. In women, pregnancy and lactation represent an additional risk due to association of physiological changes, pre-existing dyslipidemia, and limited therapeutic possibilities and experiences. Methods of extracorporeal LDL-apheresis represent a suitable therapeutic approach. CASE SERIES: We present our experience in case reports of six HoFH women and their 13 pregnancies (nine successful, three abortions, and one interruption). One patient experienced a lethal complication of her pregnancy. Of the nine successful pregnancies, two cases were treated by LDL-apheresis. CONCLUSION: Pregnancy in HoFH women represents substantial risk; however, patients without signs of decompensated cardiovascular disease can have a good prognosis. LDL-apheresis plays an important role in the management of pregnancy in HoFH.


Subject(s)
Atherosclerosis , Blood Component Removal , Cardiovascular Diseases , Homozygous Familial Hypercholesterolemia , Hyperlipoproteinemia Type II , Humans , Pregnancy , Female , Hyperlipoproteinemia Type II/complications , Hyperlipoproteinemia Type II/therapy , Hyperlipoproteinemia Type II/diagnosis , Blood Component Removal/adverse effects , Cardiovascular Diseases/etiology
SELECTION OF CITATIONS
SEARCH DETAIL
...